![]() |
![]() |
![]() |
|
June 28 - 30, 2007
OLMA Conference Center
St. Gallen
Switzerland
Product candidate:
Methylnaltrexone (subcutaneous)
Stage of Research:
Phase 3 abstract
Title: "Methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: Results of a 3-month open-label study"